Multi-Peptide Blends · Research deep dive
CJC-1295 / Ipa 2X Blend (10mg / 10mg): the cited literature
Every study referenced in the CJC-1295 / Ipa 2X Blend (10mg / 10mg) monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, CJC-1295 / Ipa 2X Blend (10mg / 10mg) is studied at 200 mcg – 400 mcg per administration, typically once nightly (combined peptide mass). The reference walkthrough below maps each citation to what it actually showed.
References covered
Synergism of GHRH and GHRPs
J. Clin. Endocrinol. Metab., 1994
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for CJC-1295 / Ipa 2X Blend (10mg / 10mg).